Amedisys Inc (STU:ADY)
€ 87 0.5 (0.58%) Market Cap: 2.89 Bil Enterprise Value: 3.24 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 85/100

Amedisys Inc at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) Transcript

Jun 23, 2020 / 05:00PM GMT
Release Date Price: €172 (-1.15%)
Matthew Richard Borsch
BMO Capital Markets Equity Research - Research Analyst

I think we're live now. Welcome to the afternoon sessions of the BMO 2020 Healthcare Conference. And again, thank you for -- thank you to all of our investor clients for being here and then a special thank you to Amedisys for participating this year. It's great to have you. Wish it could be in person, but maybe next year.

Representing the company, we've got the top management team here, the President and CEO, Paul Kusserow; CFO, Scott Ginn; and the COO, Chris Gerard. Welcome to all of you. Again, thank you very much, gentlemen, for being here.

Questions & Answers

Matthew Richard Borsch;Paul Berthold Kusserow
BMO Capital Markets Equity Research - Research Analyst;Amedisys, Inc. -

Maybe what I could ask you to start with is for investors, some of whom are less familiar with your story as degrees of familiarity vary across those who are dialed in, maybe you can give us a sort of a snapshot of who you are and where your status is now.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot